Status:

COMPLETED

Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

Lead Sponsor:

Abbott Molecular

Conditions:

Human Papillomavirus

Eligibility:

FEMALE

25+ years

Brief Summary

A prospective multicenter interventional study will be conducted to enroll women undergoing routine cervical cancer screening to collect cervical liquid-based cytology (LBC) specimen(s). For all subje...

Eligibility Criteria

Inclusion

  • Women is eligible if she meets the following:
  • Is 25 years of age or older
  • Is attending a participating clinic for routine cervical cancer screening following screening guidelines
  • Has an intact cervix
  • Is willing and able to provide documented informed consent
  • Is willing and able to undergo colposcopy, biopsy, and endocervical curettage (ECC) within 12 weeks (≤ 84 days) from the baseline visit, if required
  • Is willing and able to allow collection of two cervical cytology specimens

Exclusion

  • A women is ineligible for the study if she meets any of the following criteria:
  • Is pregnant at the time of visit or plans to become pregnant within the following 12 weeks
  • Has any known medical condition that, in the opinion of the investigator, would result in increased risk of bleeding at biopsy
  • Has a known history of excisional or ablative therapy (e.g., LEEP, cone biopsy, cervical laser surgery, or cryotherapy) to the cervix in the last 12 months prior to the baseline visit
  • Had a cervical cytology specimen collected within the last 4 months
  • Is currently participating in any diagnostic trial for cervical cancer
  • Had a complete or partial hysterectomy, either supra cervical or involving removal of the cervix
  • Is currently participating or planning to participate in any clinical trial for HPV treatment (for the duration of this study)
  • Previous participation in this study

Key Trial Info

Start Date :

February 16 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 3 2022

Estimated Enrollment :

14935 Patients enrolled

Trial Details

Trial ID

NCT04746872

Start Date

February 16 2021

End Date

November 3 2022

Last Update

February 12 2024

Active Locations (63)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 16 (63 locations)

1

University of Alabama at Birmingham Hospital

Birmingham, Alabama, United States, 35233

2

MedPharmics, LLC

Phoenix, Arizona, United States, 85012

3

Desert Bloom Family Medicine / West Valley Research Clinic, LLC

Phoenix, Arizona, United States, 85031

4

Quality of Life Medical & Research Centers, LLC

Tucson, Arizona, United States, 85712